268 related articles for article (PubMed ID: 11442342)
1. Macrolide resistance in Streptococcus pyogenes isolates from throat infections in the region of Aachen, Germany.
Brandt CM; Honscha M; Truong ND; Holland R; Hövener B; Bryskier A; Lütticken R; Reinert RR
Microb Drug Resist; 2001; 7(2):165-70. PubMed ID: 11442342
[TBL] [Abstract][Full Text] [Related]
2. Macrolide-resistant Streptococcus pyogenes in the United States, 2002-2003.
Richter SS; Heilmann KP; Beekmann SE; Miller NJ; Miller AL; Rice CL; Doern CD; Reid SD; Doern GV
Clin Infect Dis; 2005 Sep; 41(5):599-608. PubMed ID: 16080080
[TBL] [Abstract][Full Text] [Related]
3. Macrolide-resistant genes of Streptococcus pyogenes isolated from the upper respiratory tract by polymerase chain reaction.
Billal DS; Hotomi M; Yamauchi K; Fujihara K; Tamura S; Kuki K; Sugita R; Endou M; Mukaigawa J; Yamanaka N
J Infect Chemother; 2004 Apr; 10(2):115-20. PubMed ID: 15160306
[TBL] [Abstract][Full Text] [Related]
4. Phenotypic and molecular characterization of macrolide and streptogramin resistance in Streptococcus mitis from neutropenic patients.
Achour W; Guenni O; Malbruny B; Canu A; Leclercq R; Hassen AB
J Antimicrob Chemother; 2004 Jul; 54(1):117-21. PubMed ID: 15190021
[TBL] [Abstract][Full Text] [Related]
5. Activities of 16-membered ring macrolides and telithromycin against different genotypes of erythromycin-susceptible and erythromycin-resistant Streptococcus pyogenes and Streptococcus pneumoniae.
Mazzariol A; Koncan R; Vitali LA; Cornaglia G
J Antimicrob Chemother; 2007 Jun; 59(6):1171-6. PubMed ID: 17405779
[TBL] [Abstract][Full Text] [Related]
6. Telithromycin and quinupristin-dalfopristin resistance in clinical isolates of Streptococcus pyogenes: SMART Program 2001 Data.
Hsueh PR; Teng LJ; Lee CM; Huang WK; Wu TL; Wan JH; Yang D; Shyr JM; Chuang YC; Yan JJ; Lu JJ; Wu JJ; Ko WC; Chang FY; Yang YC; Lau YJ; Liu YC; Leu HS; Liu CY; Luh KT;
Antimicrob Agents Chemother; 2003 Jul; 47(7):2152-7. PubMed ID: 12821461
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of macrolide resistance in Streptococcus pyogenes collected in Serbia.
Pavlovic L; Grego E; Sipetic-Grujicic S
Jpn J Infect Dis; 2010 Jul; 63(4):275-6. PubMed ID: 20657068
[TBL] [Abstract][Full Text] [Related]
8. Streptococcus pyogenes isolates with characterized macrolide resistance mechanisms in Spain: in vitro activities of telithromycin and cethromycin.
Morosini MI; Cantón R; Loza E; del Campo R; Almaraz F; Baquero F
J Antimicrob Chemother; 2003 Jul; 52(1):50-5. PubMed ID: 12805254
[TBL] [Abstract][Full Text] [Related]
9. Molecular emm typing of Bulgarian macrolide-resistant Streptococcus pyogenes isolates.
Muhtarova A; Mihova K; Markovska R; Mitov I; Kaneva R; Gergova R
Acta Microbiol Immunol Hung; 2019 Dec; 67(1):14-17. PubMed ID: 31833385
[TBL] [Abstract][Full Text] [Related]
10. Emergence of macrolide-resistant Streptococcus pyogenes strains in French children.
Bingen E; Bidet P; Mihaila-Amrouche L; Doit C; Forcet S; Brahimi N; Bouvet A; Cohen R
Antimicrob Agents Chemother; 2004 Sep; 48(9):3559-62. PubMed ID: 15328126
[TBL] [Abstract][Full Text] [Related]
11. In vitro activity of the new ketolide telithromycin compared with those of macrolides against Streptococcus pyogenes: influences of resistance mechanisms and methodological factors.
Bemer-Melchior P; Juvin ME; Tassin S; Bryskier A; Schito GC; Drugeon HB
Antimicrob Agents Chemother; 2000 Nov; 44(11):2999-3002. PubMed ID: 11036012
[TBL] [Abstract][Full Text] [Related]
12. High macrolide resistance in Streptococcus pyogenes strains isolated from children with pharyngitis in China.
Liu X; Shen X; Chang H; Huang G; Fu Z; Zheng Y; Wang L; Li C; Liu L; Shen Y; Yang Y
Pediatr Pulmonol; 2009 May; 44(5):436-41. PubMed ID: 19360846
[TBL] [Abstract][Full Text] [Related]
13. What causes decreased erythromycin resistance in Streptococcus pyogenes? Dynamics of four clones in a southern European region from 2005 to 2012.
Montes M; Tamayo E; Mojica C; García-Arenzana JM; Esnal O; Pérez-Trallero E
J Antimicrob Chemother; 2014 Jun; 69(6):1474-82. PubMed ID: 24562616
[TBL] [Abstract][Full Text] [Related]
14. Macrolide-resistance genes in clinical isolates of Streptococcus pyogenes.
Cascone C; Santagati M; Noviello S; Iannelli F; Esposito S; Pozzi G; Stefani S
Microb Drug Resist; 2002; 8(2):129-32. PubMed ID: 12118517
[TBL] [Abstract][Full Text] [Related]
15. Molecular Characteristics of Erythromycin-Resistant Streptococcus pyogenes Strains Isolated from Children Patients in Tunis, Tunisia.
Ksia S; Smaoui H; Hraoui M; Bouafsoun A; Boutiba-Ben Boubaker I; Kechrid A
Microb Drug Resist; 2017 Jul; 23(5):633-639. PubMed ID: 27991848
[TBL] [Abstract][Full Text] [Related]
16. In vitro activity of telithromycin against macrolide-susceptible and macrolide-resistant pharyngeal isolates of group A streptococci in the United States.
Green M; Allen C; Bradley J; Dashefsky B; Gilsdorf JR; Marcon MJ; Schutze GE; Smith C; Walter E; Martin JM; Edwards KA; Barbadora KA; Rumbaugh RM; Wald ER
Antimicrob Agents Chemother; 2005 Jun; 49(6):2487-9. PubMed ID: 15917551
[TBL] [Abstract][Full Text] [Related]
17. In vitro activity of ketolides telithromycin and HMR 3004 against italian isolates of Streptococcus pyogenes and Streptococcus pneumoniae with different erythromycin susceptibility.
Giovanetti E; Montanari MP; Marchetti F; Varaldo PE
J Antimicrob Chemother; 2000 Dec; 46(6):905-8. PubMed ID: 11102408
[TBL] [Abstract][Full Text] [Related]
18. Molecular characterization of macrolide- and multidrug-resistant Streptococcus pyogenes isolated from adult patients in Barcelona, Spain (1993-2008).
Ardanuy C; Domenech A; Rolo D; Calatayud L; Tubau F; Ayats J; Martín R; Liñares J
J Antimicrob Chemother; 2010 Apr; 65(4):634-43. PubMed ID: 20118164
[TBL] [Abstract][Full Text] [Related]
19. Molecular characterization of macrolide resistant Streptococcus pyogenes isolates from pharyngitis patients in Serbia.
Opavski N; Gajic I; Borek AL; Obszańska K; Stanojevic M; Lazarevic I; Ranin L; Sitkiewicz I; Mijac V
Infect Genet Evol; 2015 Jul; 33():246-52. PubMed ID: 25976381
[TBL] [Abstract][Full Text] [Related]
20. Macrolide resistance and erythromycin resistance determinants among Belgian Streptococcus pyogenes and Streptococcus pneumoniae isolates.
Descheemaeker P; Chapelle S; Lammens C; Hauchecorne M; Wijdooghe M; Vandamme P; Ieven M; Goossens H
J Antimicrob Chemother; 2000 Feb; 45(2):167-73. PubMed ID: 10660498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
